(Press-News.org) Toronto - New research from UHN's Peter Munk Cardiac Centre (PMCC) shows statins, commonly prescribed to lower cholesterol and reduce the risk of heart disease and stroke, may also protect the heart from damaging side-effects of early breast cancer treatment.
Published Jan. 6, 2021 in the Journal of the American Heart Association, an observational study found women already taking statins and treated with either anthracyclines or trastuzumab were half as likely to be hospitalized or visit an Emergency Department for heart failure within five years after chemotherapy.
"Our job is to protect the heart and ensure it has the greatest fighting chance to get through chemotherapy," says Dr. Husam Abdel-Qadir, lead author of the paper and a cardiologist at the PMCC and Women's College Hospital. He notes prior observational studies have reported measures of heart strength in statin-treated women after chemotherapy, but only focused on a single centre.
"Our study focused on women across Ontario. We went beyond just a number indicating a weaker heart - we focused on heart failure severe enough for women to come to an Emergency Department or be hospitalized."
Anthracyclines and trastuzumab are effective therapies for many women with breast cancer. However, increased risk of cardiotoxicity has limited their use, and damage can be severe enough to lead to heart failure.
Using several health databases in Ontario, researchers reviewed the occurrence of heart failure in women aged 66 and older who received trastuzumab or anthracyclines for newly diagnosed early breast cancer between 2007 and 2017.
In the 666 pairs of women treated with anthracyclines, those taking statins were 55 per cent less likely to be treated at the hospital for heart failure. In the 390 pairs of women treated with trastuzumab, those taking statins were 54 per cent less likely, which suggested a protective trend but did not meet statistical significance.
Oxidative stress is believed to be one of the mechanisms in which cancer treatment eventually leads to damage of the heart muscle. It is defined as the imbalance of free radicals, compounds which can harm your body if levels are too high, and antioxidants, molecules that fight free radicals.
In addition to lowering cholesterol, statins may also protect the body against the effects of oxidative stress. If statins can stop this imbalance, they may decrease the likelihood the heart sustains damage due to cancer treatment.
"In order to know whether it's a true cause and effect relationship, we need to do a proper randomized control trial," says Dr. Abdel-Qadir, who is also part of the Ted Rogers Centre for Heart Research (TRCHR) Cardiotoxicity Prevention Program.
"For the time being, if a woman is supposed to be starting treatment for breast cancer and already has an established indication to be on a statin, there's now additional motivation to start it or stay on it."
As for next steps, Dr. Dinesh Thavendiranathan, cardiologist at the PMCC, lead of the TRCHR Cardiotoxicity Prevention Program and senior author on the study is currently recruiting for the SPARE-HF randomized control trial, which will assess whether pre-treatment with statins before anthracycline-chemotherapy can prevent cardiotoxicity in high-risk patients.
"It's part of the larger principles we try and apply within the TRCHR Cardiotoxicity Program, which is ideally you shouldn't change the cancer treatment, you let the oncologist pick the best treatment for the patient," says Dr. Abdel-Qadir.
"We try to reduce the risks that come with it. Our vision is that patients should be able to get the best cancer treatment while reducing concerns for the heart as much as possible."
INFORMATION:
The study was funded by the Ted Rogers Centre for Heart Research and the Canadian Cardiovascular Society.
About the Peter Munk Cardiac Centre
The Peter Munk Cardiac Centre, established through the generous support of The Peter and Melanie Munk Charitable Foundation, is the premier cardiac centre in Canada. Each year, over 163,000 patients receive innovative and compassionate care from a multidisciplinary team who treat some of the most complex cases of heart and vascular disease. Our clinical and research expertise has improved the lives of patients around the world, while we continue to train more cardiologists, cardiovascular surgeons, and vascular surgeons than any other hospital in Canada. The Peter Munk Cardiac Centre is based at Toronto General Hospital, Toronto Western Hospital and Toronto Rehabilitation Institute - all members of University Health Network. For more information, visit http://www.petermunkcardiaccentre.ca
About the University Health Network
University Health Network consists of Toronto General, recently voted one of the Top 10 Hospitals in the World according to Newsweek Magazine, and Toronto Western Hospital, the Princess Margaret Cancer Centre, Toronto Rehabilitation Institute, and the Michener Institute of Education at UHN. The scope of research and complexity of cases at University Health Network has made it a national and international source of discovery, education and patient care. It has the largest hospital-based research program in Canada, with major research in cardiology, transplantation, neurosciences, oncology, surgical innovation, infectious diseases, genomic medicine and rehabilitation medicine. University Health Network is a research hospital affiliated with the University of Toronto.
Separating infants and their mothers after a Caesarean section delivery is common. A new study published in END ...
A reduced sense of smell, or olfactory dysfunction, is one of the most common symptoms of COVID-19. A recent study published the END ...
As children undergo treatment for cancer, they may miss school and risk falling behind in their education. An analysis published in END ...
From 2007 to 2016, food insecurity--or limited access to nutritious foods because of a lack of financial resources--increased significantly from 5.5% to 12.4% among older US adults, and the increase was more pronounced among individuals with lower income. The findings come from a study published in the Journal of the American Geriatric Society.
The study, which drew from data from National Health and Nutrition Examination Surveys, also found that older adults who had food insecurity tended to have lower quality diets.
"Our results provide further evidence that food insecurity is a serious health concern among older adults. Continued investment in public health programs and policies are needed to simultaneously ...
The antimalarial drug hydroxychloroquine is frequently prescribed to treat symptoms of the autoimmune disease lupus. In addition to decreasing disease flares, the drug can also prevent blood clots, which are a major problem in individuals with lupus. A new study in Arthritis & Rheumatology shows that monitoring patients' blood levels of hydroxychloroquine can predict their clotting risk.
In 739 patients, clotting occurred in 38 patients (5.1%). Average hydroxychloroquine blood levels were lower in patients who developed clots, and clotting rates were reduced by 12% for every 200 ng/mL increase in the most recent hydroxychloroquine blood level.
The finding may help clinicians determine the optimal dosing of hydroxychloroquine ...
Individuals face a higher risk of dying following hip fractures. A new study published in the Journal of Bone and Mineral Research has found that living alone after experiencing a hip fracture may further elevate this risk.
For the study, researchers examined information on hip fractures from all hospitals in Norway from 2002 to 2013, and they combined the data with the 2001 National Population and Housing Census.
During 12.8 years of follow-up in 12,770 men and 22,067 women with hip fractures at ages 50 to 79 years, higher rates of death were seen in both men and women living alone versus those living with a partner (a 37% higher risk in men and a 23% higher risk in women).
INFORMATION: ...
Findings from a recent study of individuals with depression suggest that Mindfulness-Based Cognitive Therapy (MBCT) can improve how patients feel about themselves in difficult situations in ways that may help protect against relapse of depressive symptoms. The findings are published in Counselling and Psychotherapy Research.
For the study, 68 individuals were randomized the MBCT or a waiting list. Patients who received MBCT were more likely to experience reductions in feelings of self-inadequacy and improvements in self-reassurance. Also, individuals with improvements in self-reassurance were less likely to experience depressive relapse within 2 years after the MBCT intervention.
"Self-criticism makes people vulnerable to depression. This study ...
By late fall, much of the Midwest is a pleasing landscape of dry, harvested corn fields. It makes for a bucolic rural scene on highway drives. But the corn litter that's left over doesn't seem useful, at least to untrained eyes.
But to those in the know, that corn residue is a valuable resource. Scattered leaves, husks, kernels, and cobs can serve as food to grazing cattle. When managed well, corn residue can increase farm income, provide affordable food for cattle, and efficiently use the land to feed people.
Morgan Grabau, a member of the American Society of Agronomy, studies ...
Researchers from University of Texas at San Antonio and University of Southern California published a new paper in the Journal of Marketing that examines the difficult choices industry incumbents and new entrants face during times of potentially disruptive technological change.
The study, forthcoming in the Journal of Marketing, is titled "Leapfrogging, Cannibalization, and Survival during Disruptive Technological Change: The Critical Role of Rate of Disengagement" and is authored by Deepa Chandrasekaran, Gerard Tellis, and Gareth James.
In July 2020, Tesla became the world's most valuable automaker, surpassing Toyota in market value for the first time. Ironically, it was Toyota that in 1997 released the Prius, the world's first ...
Antibiotics are not necessary for patients after most routine endoscopic sinus surgeries despite the common practice to prescribe them, according to a team led by researchers at Massachusetts Eye and Ear.
In a new randomized controlled trial, patients who underwent endoscopic sinus surgery had no differences in outcomes including symptoms and infections whether they took an antibiotic or placebo after surgery. The only reported difference in outcomes was in side effects, with patients in the antibiotic group 10 times more likely to report symptoms like diarrhea.
The ...
